The Latest on AI4Eyes

AI research internship focused on building and stress-testing clinical AI models for dry eye disease using real-world medical data.

AI4Eyes announces the expansion of its Board of Directors, strengthening independent governance and strategic leadership as the company advances toward regulated commercialization and market scale-up.

AI4Eyes has secured $6.5 million in funding to accelerate the development and commercialization of its AI-driven eye care technology, supporting regulatory approvals, clinical validation, and global market expansion.

We’re thrilled to share that our project has been selected as one of 17 in the latest INOVAIT Pilot Fund.

AI4Eyes welcomes Dr. Claudine Courey as Head of Medical Affairs, adding strong clinical expertise to its mission of advancing AI-driven eye care.

AI4Eyes was recognized and awarded at ALL IN 2025 for its leadership in advancing AI-driven eye care.

We’re honored to spotlight Dr. Lyndon Jones—global leader in ocular research and our esteemed Scientific Advisor. From contact lens innovation to dry eye breakthroughs, his expertise propels AI4Eyes into the future of diagnostics.

AI4Eyes launches its first Health Canada and IRB-approved clinical trials, collecting real-world patient data to build the world’s largest ocular surface dataset and advance AI-powered eye care diagnostics.

Full Stack Software Developer role building and scaling production-ready, cloud-based AI software for real-world clinical eye care.

AI4Eyes CEO Dr. Tara Akhavan is featured in La Presse as a trailblazing leader in tech and inclusion. She shares how diversity isn’t just ethical-it’s a business advantage.

Real-world optometrist feedback on how the AI4Eyes OSDx Platform integrates seamlessly into the pre-test room to improve dry eye detection, workflow efficiency, and patient engagement.

AI4Eyes partners with Dry Eye Summit and MyDryEye to transform dry eye care. Together, we’re advancing AI-driven diagnostics and expanding access across Canada.

AI4Eyes is an AI-powered clinical platform that will transform ocular surface disease care by standardizing dry eye diagnosis, streamlining workflows, and enabling faster, data-driven treatment decisions—without adding friction to the clinic.